UNSPSC 51452901: Malathion topical antiparasitic

This classification denotes a pediculocide with the molecular formula C10H19O6PS2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U5N7SU872W, chemically known as 1, 2-di(ethoxycarbonyl)ethyl o,o-dimethyl phosphordithioates but generally known as malathion, which bears US NIH Compound Identifier 4004. European Medicines Agency schedules Malathion in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14453MIG.

World Health Organization schedules malathion in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule malathion topical antiparasitic under HS 29309000 and SITC 51549. SMILES: CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC.

UNSPSC 51452901 Malathion topical antiparasitic is a Commodity code that does not align with the recent state and local procurement activity associated with it in the source data. The two recorded opportunities under this code actually solicit pharmaceutical warehouse supplies (Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets) and naloxone overdose-reversal kits with drug deactivation systems—neither of which is malathion or a topical antiparasitic treatment. The mismatch between the code's nominal scope and the work actually being procured suggests either a data-entry error in the source records or a misclassification at the issuing-body level. No recent open solicitations for malathion topical antiparasitic products appear in the source.

The two opportunities on record reflect activity by a state health department and a county health authority. The Illinois Department of Public Health awarded a completed $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 (IFB 26482DPHPREPDB53392) through the MMCAP Infuse cooperative purchasing vehicle. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 with a response deadline of July 26, 2026 (note: the source date appears inconsistent, listing July 26, 2023 alongside a June 30, 2026 posting date) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The county's procurement did not specify set-aside designations but required E-Verify compliance and drug-free workplace certification, with potential FEMA funding. Without confirmed opportunities actually soliciting malathion under this code, pursue only if your firm can clarify the classification issue directly with the relevant issuing bodies or identify corrected opportunity records.